Skip to content
MedsAcross

Medicine

Amoxicillin and Clavulanate 562.5 mg/437.5 mg/62.5 mg extended-release tablet

Available on requestPrescription onlyUS FDAGeneric name

Amoxicillin and Clavulanate 562.5 mg/437.5 mg/62.5 mg extended-release tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store tablets at 20°C to 25°C (68°F to 77°F).

Key facts

Active ingredient (INN)
Amoxicillin and Clavulanate
Brand
Sold under the generic name
Strength
562.5 mg/437.5 mg/62.5 mg
Dosage form
Extended-release tablet
Route
Oral
Packs
40 tablets, 28 tablets and 2 more
Manufacturers
SandozUSAntibioticsSportpharm
Origin register
US FDA, United States
Storage
Store tablets at 20°C to 25°C (68°F to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.10Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
21 April 2010
Identifiers
RxCUI 617995DailyMed set ID cd7d2c0c-bf58-457a-b3d1-bb4c167cd127, 45c60b69-1b65-01ed-e063-6294a90a57be, e41387c8-2c74-4990-831f-64dc921ee138NDC 85766-123, 81964-220, 0781-1943Application ANDA090227, NDA050785

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
40 tablet, multilayer, extended release in 1 bottle0781-1943-39Sandoz21 April 2010
28 tablet, multilayer, extended release in 1 bottle0781-1943-82Sandoz21 April 2010
28 tablet, film coated, extended release in 1 bottle81964-220-28USAntibiotics15 December 2025
40 tablet, film coated, extended release in 1 bottle81964-220-40USAntibiotics15 December 2025
28 tablet, multilayer, extended release in 1 bottle85766-123-28Sportpharm6 November 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 6 August 1984Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Amoxicillin and Clavulanate

Clinical summary

Amoxicillin and Clavulanate is a fixed-dose combination of a penicillin-class antibacterial and a beta lactamase inhibitor indicated for the treatment of infections in adults and pediatric patients, among other approved uses. MedsAcross supplies Amoxicillin and Clavulanate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Amoxicillin and Clavulanate

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Amoxicillin and Clavulanate 562.5 mg/437.5 mg/62.5 mg extended-release tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.